• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感疫苗在老年人、儿童和孕妇群体中的负担、有效性及安全性。

Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations.

作者信息

Sullivan Sheena G, Price Olivia H, Regan Annette K

机构信息

WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, Victoria 3000, Australia.

WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

出版信息

Ther Adv Vaccines Immunother. 2019 Feb 7;7:2515135519826481. doi: 10.1177/2515135519826481. eCollection 2019.

DOI:10.1177/2515135519826481
PMID:30793097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6376509/
Abstract

Vaccination is the most practical means available for preventing influenza. Influenza vaccines require frequent updates to keep pace with antigenic drift of the virus, and the effectiveness, and sometimes the safety, of the vaccine can therefore vary from season to season. Three key populations that the World Health Organization recommends should be prioritized for influenza vaccination are pregnant women, children younger than 5 years of age and the elderly. This review discusses the burden of influenza and the safety and effectiveness profile of influenza vaccines recommended for these groups.

摘要

接种疫苗是预防流感最切实可行的方法。流感疫苗需要频繁更新以跟上病毒的抗原漂移,因此疫苗的有效性,有时还有安全性,可能会因季节而异。世界卫生组织建议应优先接种流感疫苗的三个关键人群是孕妇、5岁以下儿童和老年人。本综述讨论了流感的负担以及针对这些人群推荐的流感疫苗的安全性和有效性概况。

相似文献

1
Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations.流感疫苗在老年人、儿童和孕妇群体中的负担、有效性及安全性。
Ther Adv Vaccines Immunother. 2019 Feb 7;7:2515135519826481. doi: 10.1177/2515135519826481. eCollection 2019.
2
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].《中国季节性流感疫苗接种技术指南(2021—2022年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.
3
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].《中国季节性流感疫苗接种技术指南(2020—2021年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Oct 6;54(10):1035-1059. doi: 10.3760/cma.j.cn112150-20200911-01198.
4
[Technical guidelines for seasonal influenza vaccination in China (2023-2024)].《中国季节性流感疫苗接种技术指南(2023—2024年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Oct 10;44(10):1507-1530. doi: 10.3760/cma.j.cn112338-20230908-00139.
5
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Oct 10;43(10):1515-1544. doi: 10.3760/cma.j.cn112338-20220825-00734.
6
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.
7
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].《中国季节性流感疫苗接种技术指南(2020—2021年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1555-1576. doi: 10.3760/cma.j.cn112338-20200904-01126.
8
[Technical guidelines for seasonal influenza vaccination in China, 2019-2020].《中国2019-2020年季节性流感疫苗接种技术指南》
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Nov 10;40(11):1333-1349. doi: 10.3760/cma.j.issn.0254-6450.2019.11.002.
9
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.疫苗预防和控制季节性流感:免疫实践咨询委员会的建议-美国,2022-23 流感季节。
MMWR Recomm Rep. 2022 Aug 26;71(1):1-28. doi: 10.15585/mmwr.rr7101a1.
10
[Technical guidelines for seasonal influenza vaccination in China (2018-2019)].《中国季节性流感疫苗接种技术指南(2018—2019年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Nov 6;52(11):1101-1114. doi: 10.3760/cma.j.issn.0253-9624.2018.11.003.

引用本文的文献

1
A 14-year influenza reinfection surveillance in Chongqing, China: A retrospective analysis.中国重庆14年流感再感染监测:一项回顾性分析。
Hum Vaccin Immunother. 2025 Dec;21(1):2497576. doi: 10.1080/21645515.2025.2497576. Epub 2025 May 5.
2
Effectiveness of a theory-informed intervention to increase care home staff influenza vaccination rates: a cluster randomised controlled trial.一项基于理论的干预措施提高养老院工作人员流感疫苗接种率的有效性:一项整群随机对照试验。
J Public Health (Oxf). 2025 May 29;47(2):246-257. doi: 10.1093/pubmed/fdaf023.
3
Uncovering the Burden of Influenza-Associated Illness across Levels of Severity in the Kingdom of Saudi Arabia Across Three Seasons.揭示沙特阿拉伯王国三个季节中不同严重程度的流感相关疾病负担。
J Epidemiol Glob Health. 2025 Mar 20;15(1):47. doi: 10.1007/s44197-025-00390-1.
4
An mRNA vaccine candidate encoding cholera toxin subunit B and conserved antigens of influenza viruses confers cross-protection against influenza a viruses in adult and aged mice.一种编码霍乱毒素B亚基和流感病毒保守抗原的mRNA候选疫苗可在成年和老年小鼠中提供针对甲型流感病毒的交叉保护。
Hum Vaccin Immunother. 2025 Dec;21(1):2453304. doi: 10.1080/21645515.2025.2453304. Epub 2025 Feb 16.
5
Influenza vaccine outcomes: a meta-analysis revealing morbidity benefits amid low infection prevention.流感疫苗的效果:一项荟萃分析揭示了在预防感染效果欠佳的情况下其对发病率的益处。
Eur Respir Rev. 2025 Jan 8;34(175). doi: 10.1183/16000617.0144-2024. Print 2025 Jan.
6
Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland.初级保健中流感疫苗对有症状流感的有效性:爱尔兰2022/2023和2023/2024两个流感季节的检测阴性病例对照研究
Influenza Other Respir Viruses. 2024 Dec;18(12):e70023. doi: 10.1111/irv.70023.
7
Effectiveness of influenza vaccine among the population in Chongqing, China, 2018-2022: A test negative design-based evaluation.2018-2022 年中国重庆人群流感疫苗有效性:基于似然比检验的评估。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2376821. doi: 10.1080/21645515.2024.2376821. Epub 2024 Jul 18.
8
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine.全身初免-黏膜加强免疫显著提高了二价呼吸道合胞病毒-流感病毒载体疫苗的保护效力。
NPJ Vaccines. 2024 Jun 26;9(1):118. doi: 10.1038/s41541-024-00912-1.
9
Acceptability, cost-effectiveness, and capacity of a facility-based seasonal influenza vaccination among high-risk groups: a study protocol in selected tertiary care hospitals of Bangladesh.孟加拉国选定的三级保健医院中高风险人群季节性流感疫苗接种的可接受性、成本效益和能力:一项研究方案。
BMC Public Health. 2024 Jan 20;24(1):242. doi: 10.1186/s12889-024-17724-6.
10
Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against influenza in community-dwelling older adults 75 years and older.75岁及以上社区居住老年人中疫苗诱导的血凝抑制抗体滴度的季节间下降以及针对流感的既往体液免疫的影响因素
Immun Ageing. 2023 Jul 31;20(1):38. doi: 10.1186/s12979-023-00362-8.

本文引用的文献

1
Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.既往接种史与儿童接种活疫苗或灭活疫苗的流感疫苗效力的相关性。
JAMA Netw Open. 2018 Oct 5;1(6):e183742. doi: 10.1001/jamanetworkopen.2018.3742.
2
A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults.一项关于新型佐剂疫苗在老年人中安全性的系统评价和荟萃分析。
Vaccine. 2018 Jul 5;36(29):4207-4214. doi: 10.1016/j.vaccine.2018.06.004. Epub 2018 Jun 6.
3
Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season.更新:美国疾病预防控制中心关于使用四价活流感疫苗(LAIV4)的建议-2018-19 流感季。
MMWR Morb Mortal Wkly Rep. 2018 Jun 8;67(22):643-645. doi: 10.15585/mmwr.mm6722a5.
4
Narcolepsy Associated with Pandemrix Vaccine.与 Pandemrix 疫苗相关的发作性睡病。
Curr Neurol Neurosci Rep. 2018 Jun 1;18(7):43. doi: 10.1007/s11910-018-0851-5.
5
Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.MF59 佐剂四价流感病毒疫苗与非佐剂流感疫苗在儿童中的疗效、免疫原性和安全性评价:一项多中心、随机、对照、观察者盲、3 期临床试验。
Lancet Respir Med. 2018 May;6(5):345-356. doi: 10.1016/S2213-2600(18)30108-5. Epub 2018 Apr 6.
6
Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18.2017/18 年西班牙北部,三价流感疫苗在以流感 B 谱系错配为主的流行季节中的中期有效性。
Euro Surveill. 2018 Feb;23(7). doi: 10.2807/1560-7917.ES.2018.23.7.18-00057.
7
Impact of Timing of Influenza Vaccination in Pregnancy on Transplacental Antibody Transfer, Influenza Incidence, and Birth Outcomes: A Randomized Trial in Rural Nepal.妊娠期间流感疫苗接种时间对胎盘抗体转移、流感发病率和出生结局的影响:尼泊尔农村的一项随机试验。
Clin Infect Dis. 2018 Jul 18;67(3):334-340. doi: 10.1093/cid/ciy090.
8
Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.2017 - 18年季节性流感疫苗效力中期评估 - 美国,2018年2月
MMWR Morb Mortal Wkly Rep. 2018 Feb 16;67(6):180-185. doi: 10.15585/mmwr.mm6706a2.
9
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.2017/18 年流感疫苗效力的临时估计:2018 年 1 月加拿大甲型 H3N2 和乙型(山形)流感早期同时流行。
Euro Surveill. 2018 Feb;23(5). doi: 10.2807/1560-7917.ES.2018.23.5.18-00035.
10
Vaccines for preventing influenza in healthy children.用于预防健康儿童流感的疫苗。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004879. doi: 10.1002/14651858.CD004879.pub5.